- In 2017, Bora Health was officially established and began exclusive distribution of Japanese OTC products in Taiwan. The flagship product, Nerome, is a consistent bestseller in Taiwan’s NT$100 billion health supplement market.
Your experienced Taiwan healthcare business partner
Dedicated to helping you reach your OTC and consumer healthcare product goal.
Bora Pharmaceuticals is a leading expert in the marketing of healthcare products and pharmaceuticals in Taiwan. Renowned companies, including SSP (one of Japan’s top three pharmaceutical companies), Eisai Co., Ltd., Shionogi Healthcare, and Zeria’s healthcare and skincare products, as well as products from Boiron — France’s No.1 over-the-counter (OTC) brand — have entrusted Bora Pharmaceuticals to steer their business in the Taiwan market. Our sales network spans major distribution channels across Taiwan, and the products we distribute are highly recognized and well-received in the domestic market.
Bora Group has a professional sales team with extensive local marketing experience and a strong understanding of international regulations and pharmaceutical standards. We provide international partners with comprehensive, one-stop integrated services, covering :
Through a carefully established network of medical centers, clinics, pharmacies, and retail outlets, Bora Group not only helps partners quickly enter the Taiwan market but also effectively enhances sales performance and brand visibility while steadily expanding market share. Currently, our service offerings cover three main categories:
In April 2019, Bora signed an exclusive marketing agreement for Boiron, France’s top OTC and topical drug company. Bora Health distributes Boiron’s full product line in Taiwan.
In February 2024, Bora signed its third five-year contract with Eisai. The star product “Chocola BB” and its derivative product “LUCIS White” have shown excellent sales growth in Taiwan. Bora Health is responsible for physical retail distribution.
In September 2024, Bora Health signed an exclusive distribution agreement for Shionogi, one of Japan’s top three OTC brands. Initial market entries include health programs and Aojiru green juice, with more products to follow.
In 2025, Bora Health became the exclusive distributor in Taiwan for Japan’s Zeria Pharmaceutical. The first product launched is Japan’s top-selling liver support functional beverage, with more products expected.
Get in touch to explore new possibilities. Our team is ready to connect with you.